...
首页> 外文期刊>Toxicological sciences: An official journal of the Society of Toxicology >Hexachlorobenzene-induced early changes in ornithine decarboxylase and protein tyrosine kinase activities, polyamines and c-Myc, c-Fos and c-Jun proto-oncogenes in rat liver.
【24h】

Hexachlorobenzene-induced early changes in ornithine decarboxylase and protein tyrosine kinase activities, polyamines and c-Myc, c-Fos and c-Jun proto-oncogenes in rat liver.

机译:六氯苯诱导的大鼠肝脏中鸟氨酸脱羧酶和蛋白酪氨酸激酶活性,多胺和c-Myc,c-Fos和c-Jun原癌基因的早期变化。

获取原文
获取原文并翻译 | 示例
           

摘要

Hexachlorobenzene (HCB) is a lipophilic chemical compound that is widely distributed in the environment. HCB is known to cause liver tumors in experimental animals. In the present study the in vivo effect of HCB treatment on ornithine decarboxylase (ODC) and protein tyrosine kinase (PTK) activities, free polyamine content, and c-Myc, c-Fos, and c-Jun protein levels in rat liver were investigated. HCB (1000 mg/kg body weight) increased hepatic immunodetectable c-Myc, c-Fos, and c-Jun levels after 6 h, and ODC activity and spermine and putrescine content after 18 and 24 h, while maximum stimulation of PTK activity occurred at 12 h. PTK and ODC activities varied in a dose-dependent manner. The time-course of c-Myc, c-Fos, and c-Jun protein levels was different for each proto-oncogene. They were all elevated at the second day of treatment, while only c-Fos and c-Jun remained elevated after 10 days of HCB exposure. These data jointly suggest that the increase in ODC activity may be the consequence of proto-oncogene induction. The alterations in PTK activity suggest that the growth factor signal transduction pathway may be involved in the regulation of the proto-oncogene levels or/and ODC activity. The decrease in PTK activity after the first day, even in the presence of alpha-D-Difluoromethylornithine (DFMO), an inhibitor of ODC activity, suggests that it is not regulated by polyamines. These results may be relevant to the early molecular events involved in HCB tumor promoter activity in rat liver.
机译:六氯苯(HCB)是一种亲脂性化合物,广泛分布于环境中。已知HCB会在实验动物中引起肝脏肿瘤。在本研究中,研究了HCB处理对大鼠肝脏中鸟氨酸脱羧酶(ODC)和蛋白酪氨酸激酶(PTK)活性,游离多胺含量以及c-Myc,c-Fos和c-Jun蛋白水平的体内影响。 。 HCB(1000 mg / kg体重)在6小时后增加了肝脏免疫检测到的c-Myc,c-Fos和c-Jun水平,在18和24小时后增加了ODC活性和精胺和腐胺含量,而最大程度地刺激了PTK在12小时PTK和ODC活性以剂量依赖性方式变化。每个原癌基因的c-Myc,c-Fos和c-Jun蛋白水平随时间变化。在治疗的第二天,它们均升高,而仅暴露于HCB 10天后,c-Fos和c-Jun仍升高。这些数据共同表明,ODC活性的增加可能是原癌基因诱导的结果。 PTK活性的改变表明生长因子信号转导途径可能参与原癌基因水平或/和ODC活性的调节。即使在存在ODC活性抑制剂α-D-二氟甲基鸟氨酸(DFMO)的情况下,第一天后PTK活性的下降也表明它不受多胺的调节。这些结果可能与大鼠肝脏中HCB肿瘤启动子活性涉及的早期分子事件有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号